Institut Carnot CALYM
Created in 2011
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
401 2,341 2,273Activities
Technologies
Entity types
Location
Lyon, France
Lyon
France
Employees
Scale: 201-500
Estimated: 24
SIREN
432730919Engaged corporates
23
2 23Added in Motherbase
3 years, 8 months ago
deeptech Value proposition
Consortium dedicated to partnership-based research on lymphomas
CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere.
CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research:
2 non-profit associations:
– The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of lymphoma research
– The Lymphoma Academic Research Organisation (LYSARC), plus grande structure académique européenne dédiée aux opérations cliniques dans le domaine du lymphome.
18 teams dedicated to high-quality public research, located in universities and hospitals all across France, conducting lymphoma research projects
Lymphoma, Cancer, Partnership research, Preclinical and clinical research, translational research, clinical research, positionning, hematology, immunology, immunotherapy, antibody, blood cancer, proof of concept, clinical assay, lymphoma collection, lymphoma biomarkers, and lymphoma modelsOriginal language
Consortium dédié à la recherche partenariale sur le lymphome
CALYM est un consortium d’entités de recherche dans le domaine du lymphome labellisé depuis 2011 « Institut Carnot » : institut de recherche public/parapublic ayant des engagements forts en faveur du développement de la recherche partenariale avec le monde socio-économique.
CALYM est né de la volonté de plusieurs entités de recherche à créer un Consortium pour l’accélération de l’innovation et de son transfert dans le domaine du lymphome. Il regroupe actuellement 20 entités ayant une expertise complémentaire dans la recherche préclinique, translationnelle et clinique dans le domaine du lymphome :
2 associations de recherche à but non lucratif :
– The Lymphoma Study Association (LYSA), groupe coopérateur leader international de la recherche sur le lymphome.
– The Lymphoma Academic Research Organisation (LYSARC), plus grande structure académique européenne dédiée aux opérations cliniques dans le domaine du lymphome.
18 équipes de recherche publique d’excellence, réparties dans des universités et hôpitaux à travers la France, conduisant des projets de recherche sur le lymphome.
Consortium for lymphoma research | Calym
https://www.calym.org/en
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 11 Oct 2024 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 19 Oct 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 31 Jul 2024 | | |
 | Ministère de la Santé | Other 26 Oct 2022 | | |
 Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 24 May 2024 | | |
 Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Montpellier Méditerranée Métropole Environment, Government Administration, French metropolis | Other 8 Oct 2019 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 11 Oct 2024 | | |
 Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Jan 2023 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Nov 2024 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Jan 2023 | | |